Fig. 1
From: High baseline Tie1 level predicts poor survival in metastatic breast cancer
Flow diagram of study patient plasma samples analyzed at baseline, after six weeks’ treatment, after six months’ treatment and at final visit. Final plasma samples were taken at the final study visit and the reasons for discontinuation are presented in the chart
